November 28, 2019

InnomarLive 2019 - Commercializing in Canada

Toronto Congress Centre | 650 Dixon Road  | Toronto, ON

There are many considerations and factors when commercializing a new specialty pharmaceutical product in Canada; such as the regulatory and reimbursement framework. We are now experiencing a time whereby various stakeholders are aligning their processes to remove barriers and ensure patients have access to specialty therapeutics. This InnomarLive session will examine these changes within the healthcare ecosystem, and provide a forum for key opinion leaders to discuss the impact of commercialization, from the payer, patient, clinical and industry perspectives. 

Conference Highlights:

  • Review of the new R2D2 process between Health Canada and CADTH 
  • Commercialization opportunities with Cell and Gene Therapies 
  • Changing landscape of PMPRB regulations 
  • Manufacturer perspective on the challenges and opportunities around commercialization 
  • How private payers are evolving their HTA process and decision making 
  • The importance of bringing new therapies to Canada from a patient perspective 

Guest Speakers include:

  • CHAIR: Durhane Wong-Rieger, CORD
  • Trevor Richter, CADTH  
  • Megan Bettle, Health Canada  
  • Sang Mi Lee, pCPA  
  • Sylvie Bouchard, Institut national d'excellence en santé et en services sociaux (INESSS)
  • Daniel Chiasson, Canadian Association for Pharmacy Distribution Management (CAPDM)
  • Bobby Currie, The Great-West Life Assurance Company
  • Daria O'Reilly, TELUS Health
  • Ned Pojskic, Green Shield Canada
  • Anne Tomalin, TPIreg
  • Ian Stedman, Patient Advocate, Canadian CAPS Network 
  • Siofradh McMahon, CCRM
  • Pamela Fralick, Innovative Medicines Canada 
  • Eric Tse, Industry Executive 
  • Don Husereau, Adjunct Professor, University of Ottawa 

You Should Attend If You Work In:

  • Market Access / Reimbursement 
  • Regulatory Affairs 
  • Marketing / Market Research 
  • Stakeholder Relations / Government Affairs 
  • Drug Plan Management - Public & Private Payers 
  • New Product Launches / Drug Commercialization 

Pricing—Full Day Conference

  • $750 – 1 attendee
  • $700 p/p – 2 to 5 attendees
  • $650 p/p – 5 to 7 attendees
  • $600 p/p – 8+ attendees

Reserve Your Spot Today!

For more information contact:
Alison Drinkwater
905-681-6551 x7410

* Please note: You may use a credit card or choose to be invoiced by Innomar Strategies. 

InnomarLive 2020 - Patient Support Programs: Today, Tomorrow and the Future

12/14/2020 12:00:00 PM - 12/17/2020 1:00:00 PM

Life Sciences Ontario - Annual Policy Forum

11/2/2020 9:00:00 AM - 11/6/2020 2:00:00 PM

Webinar: 2020 pCODR Updates

9/9/2020 12:00:00 PM - 9/9/2020 1:00:00 PM